© 2021 MJH Life Sciences and Drug Topics. All rights reserved.
© 2021 MJH Life Sciences™ and Drug Topics. All rights reserved.
Yupelri (revefenacin, Mylan®)
Indications: Patients with chronic obstructive pulmonary disease
Dosage: One 175 mcg vial (3 mL) once daily.
Contraindications: hypersensitivity to revefenacin or any component of this product.
Click here for more prescribing information